Liu et al. [98] discovered that LncRNA-PACERR was increased in PC leading to enhanced tumor development, and LncRNA-PACERR promoted pancreatic cancer development by acting on IGF2BP2. This evidence concerns the gene IGF2BP2 and pachyonychia congenita.